JPMP MASTER FUND MANAGER L P's Net Worth

$53.7 Million

Estimate Recalculated Apr 9, 2025 05:32PM EST

Who is JPMP MASTER FUND MANAGER L P?

JPMP MASTER FUND MANAGER L P has an estimated net worth of $53.7 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, PHARMOS CORP, EYETECH PHARMACEUTICALS INC, BARRIER THERAPEUTICS INC, CORGENTECH INC, PortalPlayer, Inc., BILL BARRETT CORP, CMGI INC, SANTARUS INC, WARNER CHILCOTT PLC, 1 800 FLOWERS COM INC, NUCO2 INC /FL, HOME PRODUCTS INTERNATIONAL INC, ENCORE ACQUISITION CO, COMSCORE, INC., ARAMARK Holdings Corp, Emergent BioSolutions Inc., HANGER ORTHOPEDIC GROUP INC, ICAGEN INC, Kraton Performance Polymers, Inc., Warner Chilcott Ltd, MYOGEN INC, CANDLEWOOD HOTEL CO INC, ARAMARK CORP, ARAMARK CORP/DE, PLIANT CORP, CARRIZO OIL & GAS INC, CROWN MEDIA HOLDINGS INC, and GUITAR CENTER INC.

SEC CIK

JPMP MASTER FUND MANAGER L P's CIK is 0001243235

Past Insider Trading and Trends

2004 was JPMP MASTER FUND MANAGER L P's most active year for disposing of shares, totalling 4 transactions. JPMP MASTER FUND MANAGER L P's most active month to dispose stocks was the month of July. In 2004 JPMP MASTER FUND MANAGER L P cashed out on 1,059,996 shares for a total of $1,252,208.58, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SEATTLE GENETICS INC /WA (SGEN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.20%
-21.50K
$10.36
-$222,740.00
1.77M
Jul 25 - Jul 28
Form 4
-7.94%
-150.00K
$10.81
-$1,621,500.00
1.74M
Jul 25
Form 4
-5.57%
-122.89K
$10.10
-$1,241,219.30
2.08M
May 14
Form 4
-2.28%
-51.54K
$10.06
-$518,452.16
2.2M
May 13
Form 4/A
∞
4.49M
—
—
4.49M
Jul 9
Form 4
+149,500.00%
4.49M
—
—
4.49M
Feb 9 - Jul 9
Form 4
—
0
—
—
0
May 25
Form 4
+0.05%
270
$8.57
-$17,266,236.10
522.22K
Feb 9
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Apr 6
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Dec 30
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
May 17
Form 3
—
0
—
—
0
No matching records found

PHARMOS CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jan 23
Form 4/A
—
0
—
—
0
Jan 17
Form 3
—
0
—
—
0
No matching records found

EYETECH PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.92%
43.75K
$1.44
$63,000.00
2.32M
Nov 7
Form 4
-100.00%
-2.32M
—
—
0
Nov 14
Form 4
+1.56%
35K
$0.01
$350.00
2.28M
Jun 28
Form 4
—
0
—
—
0
May 11
Form 4
-30.86%
-1.00M
$41.26
-$41,260,000.00
2.24M
Oct 28
Form 4/A
+33.33%
4.05M
$7.00
$3,333,326.00
16.2M
Feb 4
Form 4
-20.00%
-810.22K
$38.50
-$31,193,585.50
3.24M
Jun 2
Form 4
—
0
—
—
0
May 12
Form 4
+33.33%
4.29M
$7.00
$4,999,998.00
17.16M
Feb 4
Form 3
—
0
—
—
0
No matching records found

BARRIER THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.66M
$4.15
-$11,025,886.00
0
Aug 5 - Aug 6
Form 4
—
0
—
—
0
Jun 6
Form 4
-16.37%
-491.43K
$18.33
-$9,007,966.89
2.51M
Feb 15
Form 4
—
0
$7.94
—
2.47M
Dec 30
Form 4
∞
3.15M
—
—
3.15M
Apr 28
Form 3
—
0
—
—
0
No matching records found

ANESIVA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 22
Form 4
+252.20%
2.41M
—
—
3.37M
Dec 15 - Dec 16
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
$5.15
—
3.12M
Dec 30
Form 4
-15.36%
-694.44K
$17.70
-$12,291,658.80
3.83M
Nov 17
Form 4
∞
4.52M
—
—
4.52M
Feb 18
Form 3
—
0
—
—
0
No matching records found